Objective. To establish an unbiased, 3-dimensional (3-D) approach that quantifies subchondral bone plate (SBP) changes in mouse joints, and to investigate the mechanism that mediates SBP sclerosis at a late stage of osteoarthritis (OA).
and animal studies over the past several decades have accumulated sufficient evidence to support the concept that OA is a disease of the whole joint, involving changes not only in articular cartilage but also in its neighboring tissue, such as subchondral bone, ligaments, menisci, periarticular muscles, peripheral nerves, and synovium (1) . Indeed, the first radiographic criteria for the diagnosis of OA, developed in the 1950s, included subchondral sclerosis as a hallmark of this disease (2) .
Anatomically, subchondral bone consists of 2 parts: a layer of corticalized subchondral bone plate (SBP) and the underlying subchondral trabecular bone (STB). It is important to distinguish these 2 subchondral bone components in OA research, not only because they have intrinsic architectural and mechanical differences, but also because different pathologic changes can occur in each component during OA development (3) . Thickening of the SBP is considered an indisputable sign of late-stage OA (4) . However, the underlying mechanisms responsible for such thickening are still largely unknown. In the STB, the bone remodeling rate is consistently increased during the progression of OA, leading to undermineralized bone tissue and reduced mechanical strength of the trabecular bone (5) (6) (7) . Several mechanisms to explain this phenomenon have been proposed, such as cellular signaling for microdamage repair, stimulation of vascular invasion, and bone-cartilage cross-talk occurring via channels in the SBP (8) . Interestingly, results of recent studies have shown that modifying osteoblastic gene expression or inhibiting osteoclastic bone resorption could prevent the progression of OA in mice (9) , suggesting that subchondral bone activity may control articular cartilage degeneration. Currently, it is still largely under debate whether subchondral bone sclerosis is the initiator of cartilage damage or the consequence of such damage.
Research on subchondral bone has been performed mostly in human OA joints as well as in non-rodent animal models with subchondrondral bone sizes larger than that of rodents. To elucidate the molecular mechanisms regulating the SBP and STB in OA, genetically modified mice are powerful tools. Micro-computed tomography (micro-CT) is commonly used to characterize subchondral bone changes in mice. Generally, the proximal tibia is scanned at a relatively low resolution (10-20 lm) and then contoured for 3-dimensional (3-D) analysis of the STB. Because the proximal tibia of mice is relatively small in size, the results might not be accurate. Measuring the thickness of the SBP is particularly troublesome, because it is usually performed on longitudinally sectioned, 2-D images of the tibia. The results could be highly variable, due to the inconsistency of sectioning angle and location. Furthermore, since it is based on 2-D images, this approach does not capture changes in the entire SBP. Thus, there is an urgent need to design an unbiased, 3-D approach to accurately quantify the bone parameters of the SBP and STB in mouse joints.
In this study, we designed a protocol that is capable of measuring SBP thickness at any location within the mouse femoral condyle, allowing comparisons among different anatomic sites (anterior versus posterior, medial versus lateral). Utilizing this 3-D analytic tool, we examined SBP changes in several mouse models of severe latestage OA, either surgery-induced or spontaneously developing in aging mice, with the use of genetically modified and unmodified mice. Biomechanical factors, such as those seen in obesity, trauma, and joint injury, play central roles in the development and progression of OA (10) . Sclerostin (gene form Sost), a canonical, anti-osteogenic Wnt inhibitor whose expression is largely restricted to osteocytes (11, 12) , is an important mediator of mechanical loading-induced new bone formation (13) . Targeting this protein with a neutralizing antibody is a novel therapeutic strategy that is currently being developed for patients with osteoporosis (14) . In the present study, we explored potential relationships among mechanical loading, sclerostin levels, and SBP thickness under either normal or pathologic conditions in several mouse models of OA. The results of our studies reveal a novel mechanism to explain how cartilage degeneration can lead to the development of SBP sclerosis specifically underlying the sites of cartilage damage.
MATERIALS AND METHODS
Animals. Mice with cartilage-specific knockout of the endothelial growth factor receptor (EGFR) gene (Egfr-CKO; Col2-Cre Egfr Wa5/f ) were generated as previously described (15 ) siblings. Wa5 is a dominantnegative allele of Egfr (16) and is required in order to reduce the activity of EGFR to a very low level in Egfr-CKO mice (15) . We previously reported that Wa5 mice are morphologically and functionally closer to WT mice than to Egfr-CKO mice, which can be attributed to the fact that EGFR activity is only modestly decreased in Wa5 mouse cells but drastically reduced in Egfr-CKO mouse cells (15, (17) (18) (19) . We made similar observations in the present study, and therefore all data on Wa5 mice were omitted.
Rosa-Tomato mice were purchased from The Jackson Laboratory. To construct Egfr-CKO Rosa-Tomato mice, we first obtained Egfr f/f Rosa-Tomato-homozygous mice, and then used these mice to breed with Col2-Cre Egfr Wa5/+ mice. As an additional model, Sost-knockout (Sost-KO) mice were used (kindly provided by Novartis Pharma AG).
To induce OA, destabilization of the medial meniscus (DMM) or DMM plus hemisectomy of the meniscus (DMMH) surgery was performed on the right knees of 2-month-old male mice (for DMMH) (20) or 3-month-old male mice (for DMM) (21) . Sham surgery was performed on the left knees. In accordance with the standards for animal housing, mice were grouphoused in an atmosphere of 23-25°C with a 12-hour light/dark cycle, and allowed free access to water and standard laboratory pellets. All work performed on animals was approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania.
Micro-CT analysis. After the mice were euthanized, the knee joints were harvested, fixed in 4% paraformaldehyde for 2 days, rinsed with running water, and stored in 19 phosphate buffered saline. A 3-mm region from the distal femur and 3-mm region from the proximal tibia were each scanned with a Scanco Medical MicroCT 35 scanner at a 6-lm isotropic voxel size. All images were smoothened using a Gaussian filter (sigma 1.2, support 2.0).
For analysis of the STB, sagittal images were thresholded, corresponding to 472.1 mg HA/cm 3 , and contoured between the SBP and growth plate. The bone parameters of bone volume fraction/total volume (BV/TV), trabecular thickness, trabecular separation, trabecular number, and structure model index were each calculated using 3-D standard microstructural analysis (22) . For analysis of the SBP, sagittal images were contoured for the SBP, followed by generation of a 3-D color map of thickness for the entire SBP. This map was converted to a gray-scale thickness map, whose histogram was then used for quantification of the average SBP thickness at any defined area.
Histology. After the mouse knee joints were scanned by micro-CT, they were decalcified in 0.5M EDTA (pH 7.4) for 4 weeks prior to paraffin embedding. A series of 6-lmthick sagittal sections were cut across the entire medial and lateral compartments of the joint. Mankin scores for the severity of OA cartilage degeneration (scale of 0-14, where 0 = normal intact cartilage, 1-5 = mild-to-moderate OA, 6-14 = moderate-to-severe late-stage OA) were calculated as previously described (23) . Briefly, 2 sections within every 6 consecutive sections in the entire section set for each knee were stained with Safranin O-fast green; the stained sections were then scored by 2 blinded observers (HJ and XM). Each knee compartment received a single Mankin score, representing the maximal score of its section.
Additional paraffin-embedded knee joint sections, derived from the middle of the medial or lateral parts of the knee joints, were used for immunohistochemical analyses. After antigen retrieval, slides were incubated at 4°C overnight with primary antibodies, such as rabbit anti-osteocalcin (m173; Takara ClonTech) and goat anti-sclerostin (AF1589; R&D Systems), followed by binding with biotinylated secondary antibodies and color development with diaminobenzidine. The images of each section under the same conditions were captured using a Nikon Eclipse 90i microscope.
For quantification of osteoblasts, we counted all osteocalcein-positive cells along the SBP surface at the bone marrow side, underneath the articular cartilage within the femoral-tibial contact region; osteoblast numbers were normalized against the length of the SBP surface. For quantification of the staining intensity of sclerostin expression in osteocytes, the entire SBP region underneath the articular cartilage was contoured, and its staining intensity was quantified by the mean gray value after thresholding to remove background staining. Frozen sections were used for immunofluorescence staining. Frontal sections (90 lm in thickness) at the center of the posterior region were incubated with endomucin antibody (sc-65495; Santa Cruz Biotechnology) at 4°C overnight, followed by Alexa Fluor 488-conjugated donkey anti-rabbit IgG secondary antibody (A-21206; Thermo Scientific). The samples were scanned using an LSM710 confocal microscope, and images were processed and analyzed using Velocity software. The length of the SBP surface at the bone marrow side that was aligned with blood vessels was measured and normalized against the total length of the SBP surface. In all analyses, the SBP regions or surfaces that did not have overlying articular cartilage were excluded.
Statistical analysis. Data are expressed as the mean AE SD. Two-way analysis of variance was performed when 2 independent variables (sham versus DMM surgery, WT versus Egfr-CKO genotype) were compared. When there was a significant interaction effect between treatment and genotype, Mann-Whitney U test with Bonferroni adjustment for multiple comparisons was performed to test the difference between surgery groups within each genotype, as well as differences between genotypes within each group. In a scenario in which a single independent variable was considered for comparisons, Mann-Whitney U test was performed. Specifically, paired U tests were performed for comparisons between surgery groups (sham versus DMM) and between anatomic locations (anterior versus posterior, medial versus lateral), while unpaired U tests were performed for comparisons between mouse genotypes (WT versus either Egfr-CKO or Sost-KO mice). Two-sided P values less than 0.05 were considered significant.
RESULTS
Positive correlation of SBP thickness with loading status in a normal mouse knee, as revealed by micro-CT. Examination of the 3-D-reconstructed micro-CT images of an adult mouse knee joint, in a series of evenly divided frontal sections of the joint, indicated that the distal femoral subchondral region was much larger and thicker than the proximal tibial subchondral region ( Figures 1A and B) . On average, the height of the tibial STB was 180 lm across the entire plateau. This limited height prevents precise segregation of the SBP and STB in most images, even when the bone is scanned at the highest resolution. In contrast, structural analysis of subchondral bone is better performed in the femur (with an average height of~600 lm) despite sectioning of the bone into sagittal, frontal, and transverse planes.
Unlike human knee joints, mouse knee joints are unable to fully extend. As shown in Figure 1C , their bending angle is between~30°and~150°. This results in the posterior part, but not the anterior part, of the distal femoral condyle being in direct contact with the tibial plateau, and therefore the posterior part is the area that undergoes load bearing and energy dissipation during joint motion. Interestingly, in sagittal images of the normal mouse knee joint, the posterior region appeared to have a thicker SBP relative to the anterior region ( Figure 1D ).
To quantify SBP thickness at any given area, we designed a new protocol to convert the micro-CT images into a 3-D color map, in which the color at any position linearly corresponds to its SBP thickness. Using this method, we can manually define the region of interest within the SBP and calculate the average thickness within this region ( Figure 1E ). Quantification of the SBP thickness in a normal mouse knee joint confirmed that the posterior SBP of the femoral condyle at the medial and lateral sites was 2.2-fold and 1.6-fold thicker, respectively, compared to the anterior medial and lateral SBP sites ( Figure 1F ). These results provide the first line of evidence that SBP thickness is positively correlated with loading status. Since tibial SBP is very close to the growth plate, it is difficult to apply this approach to the tibia. Therefore, we focused on the distal femur for analyses of the STB and SBP in our studies.
Development of SBP sclerosis at the medial posterior site in Egfr-CKO mice after DMM. We previously reported that the activity of EGFR is critical for maintaining the number of superficial chondrocytes, promoting cartilage surface lubrication, and retaining cartilage mechanical functions (17) . Strikingly, Egfr-CKO (Col2-Cre Egfr Wa5/f ) mice developed a severe OA phenotype at 2-3 months after DMM surgery, with a complete depletion of the articular cartilage layer at the medial posterior site (see Supplementary Figure 1A Micro-CT analysis of the femoral STB detected a modest but significant decrease in the BV/TV, accompanied by reduced trabecular thickness, in the knee sections from Egfr-CKO mice, but not in those from WT mice, after DMM (see Supplementary Figure 2 , http://onlinelibrary.wiley.com/doi/10.1002/art.40351/abstract). Interestingly, progression of OA induced a drastic increase in the structure model index of the STB in Egfr-CKO mice, indicating that a deterioration of the trabecular structure occurs in late-stage OA.
Examination of the 2-D micro-CT images of frontal knee sections indicated that the SBP at the medial site of the femurs of Egfr-CKO mice was substantially thickened after DMM (Figure 2A) . By applying our new protocol, we calculated the SBP thickness at 4 locations within the femoral condyle (medial posterior, lateral posterior, medial anterior, and lateral anterior). Interestingly, in Egfr-CKO mice after DMM, we observed a significant increase in SBP thickness (increase of 31%) only at the medial posterior site, an area where cartilage degradation was the most severe (see Supplementary  Figure 1 ). This thickening of the SBP was absent from the other 3 sites of the femoral condyles of Egfr-CKO mice after DMM, and was absent from all 4 sites in WT mice ( Figures 2B and C) , implying that this localized SBP response can likely be attributed to depletion of the overlying articular cartilage.
SBP thickening in Egfr-CKO mice after DMM coinciding with increased bone formation at the bone marrow side of the SBP and reduced sclerostin levels in the SBP. To elucidate the mechanism of SBP thickening, we first investigated the sites of new bone formation. In Egfr-CKO mice after DMM surgery, osteocalcin staining revealed that the number of osteoblasts lining the SBP at the bone marrow side was increased 8.6-fold at the medial side of the femur as compared to the lateral side. Moreover, the number of osteoblasts lining the SBP at the bone marrow side was increased 9.7-fold in DMM-operated femurs compared to sham-operated femurs ( Figures 3A and B) . This enhanced bone formation was accompanied by an increased length of blood vessels lining the SBP surface ( Figures 3C and D) , likely providing more oxygen and nutrients needed for active bone formation. Wnt proteins are potent signals for osteoblastic bone formation. Sclerostin is a Wnt pathway antagonist that is almost exclusively secreted by osteocytes (12) . Interestingly, its expression is mainly regulated by mechanical stimulation on bone (13) . It is commonly accepted that in normal joints, the meniscus plays a key role in reducing the contact stresses on articular cartilage (24) , and that a loss of cartilage in the later stages of OA results in greatly amplified focal stresses on the underlying subchondral bone (25) . Therefore, we hypothesized that expression of sclerostin is Results are the mean AE SD (n = 4 mice per genotype). ** = P < 0.01; *** = P < 0.001. E, Immunohistochemical analyses were performed to determine the level of sclerostin staining intensity in the SBP. Bar = 30 lm. F, Sclerostin staining intensity was quantified. Results are the mean AE SD (n = 4 mice per genotype). *** = P < 0.001. T = tibia; AC = articular cartilage (see Figure 2 for other definitions). Color figure can be viewed in the online issue, which is available at http://onlinelibrary. wiley.com/doi/10.1002/art.40351/abstract.
specifically down-regulated in the SBP under the damaged cartilage of mice after DMM, due to abnormal overloading. Similar to the findings in the cortical bone, osteocytes in the SBP expressed high amounts of sclerostin within cell bodies and throughout dendritic processes ( Figure 3E ), indicating that sclerostin may have a possible role in maintaining the SBP. In WT mice, DMM surgery did not alter the levels of sclerostin at either the medial or the lateral sites ( Figures 3E and F) . Strikingly, in Egfr-CKO mice, the amount of sclerostin was markedly attenuated within the SBP at the medial site, but not the lateral site, of the femurs after DMM surgery ( Figures 3E and F) . These results suggest that a loss of sclerostin in the SBP underneath the damaged cartilage during late-stage OA may play a role in new bone formation at the bone marrow side of the SBP. Similar mechanisms of SBP thickening in DMMoperated Egfr-CKO mouse knees and knees of older Egfr-CKO mice with spontaneous OA. Egfr-CKO mice were previously observed to develop spontaneous OA with no SBP phenotype at 6 months of age (17) . In the present study, in mice at age 12 months, while typical OA phenotypes in the articular cartilage continued ( Figures 4A  and B) , the STB displayed significant bone loss accompanied by deterioration in structure (see Supplementary  Figure 3 , http://onlinelibrary.wiley.com/doi/10.1002/art.40351/ abstract).
Unlike surgery-induced OA in mice, age-related spontaneous OA in 12-month-old mice was characterized by cartilage damage at both the medial and lateral regions. This was associated with a similar level of SBP sclerosis at the posterior site, across the entire distal femur, in Egfr-CKO mice (Figures 4C and D) . WT mouse knees remained healthy at this age. We found that the number of osteoblasts was elevated by 4.3-and 5.4-fold at the medial and lateral sites, respectively, in Egfr-CKO mice compared to WT mice ( Figures 4E and F) .
Analysis of sections of the mouse knee joints by dynamic histomorphometry revealed that newly formed bone surfaces were observed only at the bone marrow side of the SBP, and not at the cartilage side (see Supplementary Figure 4A , http://onlinelibrary.wiley.com/doi/10. 1002/art.40351/abstract). Moreover, the bone formation Figure 4 . Increased bone formation along the SBP surface and suppressed sclerostin levels in the SBP upon SBP thickening in the knees of older Egfr-CKO mice. A, Safranin O staining was used to evaluate cartilage damage in the epiphyseal regions of the femur (F) and tibia (T) (medial and lateral sites) of 1-year-old WT and Egfr-CKO mice. Bar = 200 lm. B, Severity of osteoarthritis was measured using the Mankin score (scale 0-14). Results are the mean AE SD (n = 5 mice per genotype). * = P < 0.05. C, Representative 3-dimensional color maps show SBP thickness in WT and Egfr-CKO mouse femurs. Color ranges from 0 (blue) to 300 lm (red). D, SBP thickness at 4 distinct femoral sites is shown. Results are the mean AE SD (n = 9-11 mice per genotype). * = P < 0.05. E, Immunohistochemical analyses of osteocalcin were performed to identify osteoblasts beneath the SBP in WT and Egfr-CKO mice. Arrowheads indicate increased numbers of osteoblasts along the SBP surface. Bar = 100 lm. F, The number of osteoblasts lining the SBP surface was quantified. Results are the mean AE SD osteoblasts per bone surface area (OB/BS) (n = 4 mice per genotype). * = P < 0.05. G, Immunohistochemical analyses were performed to determine the level of sclerostin staining intensity in the SBP of the femurs in aging WT and Egfr-CKO mice. Bar = 30 lm. H, Sclerostin staining intensity was quantified in the medial and lateral sites of the femurs of aging WT and Egfr-CKO mice. Results are the mean AE SD (n = 4 mice per genotype). * = P < 0.05. BM = bone marrow (see Figure 2 for other definitions). Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.40351/abstract. rate (BFR) was elevated 3.5-fold at both the medial and lateral sites of the femurs of Egfr-CKO mice compared to WT mice (see Supplementary Figures 4B and C) . Furthermore, the levels of sclerostin expression by osteocytes in the SBP were significantly decreased at both the medial and lateral sites of the femurs of Egfr-CKO mice compared to WT mice (Figures 4G and H) .
SBP sclerosis in other models of late-stage OA. To confirm that our findings were not restricted to Egfr-CKO mice, we tested 2 other late-stage OA models in WT mice. At 10 months after DMM surgery, WT mice exhibited severe OA phenotypes, including a complete depletion of articular cartilage ( Figures 5A and B) and a trend toward bone loss in the STB (see Supplementary Figure 5 , http://onlinelibrary.wiley.com/doi/10.1002/ art.40351/abstract). Consistent with the findings in our Egfr-CKO mouse model of DMM-induced OA, the DMM-operated femurs of WT mice at 10 months after surgery displayed thickening of the SBP only at the medial posterior site, and not at the other 3 sites of the femoral condyle ( Figures 5C and D) . Staining of osteocytes in the SBP confirmed that osteocytic sclerostin levels were reduced within the thickened SBP at 10 months after DMM surgery ( Figures 5E and F) .
Compared to DMM, which produces only moderate OA, DMMH induces more severe OA (20) . At 14 weeks post-DMMH surgery, WT mouse knee joints had already developed late-stage OA phenotypes, with severe cartilage degeneration at the medial posterior site (Figures 6A and B) . No significant signs of cartilage degeneration were observed in the sham-operated joints. Thus, SBP thickening was evident only at the medial posterior site, and not at the lateral posterior site, of the femurs of WT mice at 14 weeks after DMMH (Figures 6C and D) . Moreover, we observed a significant decrease in the levels of sclerostin only at the medial site, and not at the lateral site, of DMMH-operated mouse knees ( Figure 6F ).
To determine whether inhibition of sclerostin mediates SBP sclerosis, we performed DMMH surgery on the knee joints of Sost-KO mice. Consistent with the findings reported previously (26) , the sham-operated joints of Sost-KO mice had much more subchondral bone compared to the sham-operated joints of WT mice. Strikingly, although the medial posterior site of Figure 5 . Severe cartilage degeneration accompanied by substantial SBP thickening and suppression of sclerostin within the SBP in the knees of WT mice at 10 months after DMM surgery. A, Safranin O staining was used to evaluate cartilage damage in the femur (F) and tibia (T) of WT mice at 10 months after sham or DMM surgery. Bar = 100 lm. B, Severity of osteoarthritis was measured using the Mankin score (scale 0-14). Results are the mean AE SD (n = 3 mice per group). ** = P < 0.01. C, Representative 3-dimensional color maps show SBP thickness in the shamand DMM-operated femurs of WT mice. Color ranges from 0 (blue) to 420 lm (red). D, SBP thickness at 4 distinct femoral sites is shown. Results are the mean AE SD (n = 3 mice per group). * = P < 0.05. E, Immunohistochemical analyses were performed to determine the level of sclerostin staining intensity at the medial posterior site of the SBP. The broken line indicates the chondral-osseous junction. Bar = 100 lm. F, Sclerostin staining intensity was quantified. Results are the mean AE SD (n = 3 mice per group). ** = P < 0.01. AC = articular cartilage (see Figure 2 for other definitions). Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.40351/abstract. the DMMH-operated joints developed a level of cartilage degeneration that was similar to that in WT mice ( Figures 6A and B) , the SBP thickness in the DMMHoperated joints was the same as that in the sham-operated joints (Figures 6C and E) . Taken together, our data from these OA models support the notion that SBP sclerosis is likely the result of reduced osteocyte expression of sclerostin in the SBP during the progression of OA.
DISCUSSION
Abnormal mechanical loading plays a pivotal role in the development of OA (27) . The major risk factors for knee OA that have been identified to date include older age, female sex, obesity, knee injury, and occupational overuse of the knee joints (28, 29) . While the first 2 factors are indicative of the vulnerability of the knee to injury, the latter 3 represent the presence of either chronic stress, excessive loading, or focally increased stress on the knee. Most previous studies focused on the mechanobiology of chondrocytes and cartilage tissue in their attempt to understand the role of overloading in the initiation and progression of OA (30) . In patients with OA, it has been long observed that subchondral bone becomes abnormal with increased bone resorption (31) . In this study, we took advantage of 4 models of severe late-stage OA both in genetically modified mice and in WT mice, and we demonstrated that abnormal overloading, as a result of depletion of the overlying cartilage, attenuates osteocytic sclerostin expression within the SBP, and subsequently increases bone formation at the bone marrow side of the SBP, presumably via the activation of Wnt signaling. Thus, our findings elucidate the intimate relationship among mechanical loading, osteocytic sclerostin, and SBP sclerosis during late-stage OA. This conclusion is further supported by the results of a recent study in which sclerostin levels within the SBP in patients with OA were found to be negatively correlated with OA severity (32) .
A prerequisite to reaching our conclusions was the use of a novel micro-CT protocol in which we calculated SBP thickness in a 3-D manner across the entire femoral epiphyseal area. This method eliminates bias arising from sectioning angle and location. Moreover, this approach allows us to compare the same region among different bones and different anatomic sites within the same bone, thus decreasing sample variations. Because of the small size of mouse joints, we have found that the distal femur is a better site than the proximal tibia for analysis of mouse subchondral bone under normal conditions. After mouse knee joints are subjected to DMM, SBP thickening in the tibia often results in fusion of the SBP with the growth plate, making it impossible to analyze bone structure. Several lines of evidence support our conclusion. First, our analysis of the distal femoral epiphyseal bone revealed that the load-bearing posterior site is thicker than the non-load-bearing anterior site of the same bone, regardless of whether this was observed in the medial location or lateral location. These findings indicate that SBP thickness is positively correlated with the loading applied to it.
Second, we tested 4 distinct mouse models of either severe OA or long-term chronic OA symptoms. In all models, we observed a substantial decrease in sclerostin levels expressed by osteocytes within the thickened SBP underlying damaged articular cartilage. This phenomenon is location specific. In surgery models (Egfr-CKO mice at 2 months after DMM, WT mice at 10 months after DMM, and WT mice at 14 weeks after DMMH), the SBP was expanded and the amount of sclerostin was attenuated only at the medial posterior site, an area where cartilage damage was the most concentrated. The SBP responses were not detected at the lateral posterior site, where cartilage damage was modest at best. In contrast, since we observed that OA-induced cartilage degeneration developed chronically at both the medial and lateral sites of the femoral condyles of 12-month-old Egfr-CKO mice with spontaneous, agingrelated OA, alterations in the SBP were correspondingly observed at both the lateral and medial posterior sites.
Third, despite the occurrence of changes in the posterior region, the thickness of the anterior SBP, regardless of whether it was located in the medial site or the posterior site, remained the same in all of our OA models.
Finally, our findings in Sost-KO mice after DMMH surgery support the idea that sclerostin mediates SBP thickening underneath the eroded cartilage at the late stages of OA. Repetitive mechanical loading on diaphyseal cortical bone reduces sclerostin expression to achieve anabolic bone formation (33) . Indeed, the SBP is structurally similar to cortical bone and has higher sclerostin levels when compared to trabecular bone (data not shown). It is very likely that the suppressed expression of sclerostin that was observed in the SBP underneath the damaged cartilage could be attributed to the increased focal stress on the SBP. Therefore, our data provide another piece of evidence supporting the role of sclerostin in the bone responses toward mechanical loading. Taken together, our findings demonstrate a critical role of mechanics in shaping the SBP after the development of OA, and elucidate the underlying molecular mechanism.
Interestingly, in the Egfr-CKO mouse models of OA, in addition to thickening of the SBP, the STB became modestly osteopenic. Our previous study demonstrated that metaphyseal trabecular bone and serum bone markers are not affected in Egfr-CKO mice (17) , indicating that overall, bone remodeling is not altered as a consequence of the genetic modification of Egfr in cartilage. This result is consistent with a previous finding indicating that OAinduced bone damage is restricted to the subchondral bone region (34) . We believe that defects in articular cartilage are sufficient to induce subchondral bone abnormalities under enhanced mechanical loads.
Whether subchondral bone sclerosis is a driving force for cartilage degeneration or a consequence of cartilage degeneration has been disputed for many years. Since the DMM surgery used in our current model led to the development of moderately severe OA in WT mice, we only detected significant changes in the SBP and STB at 10 months after surgery. At 2 months after surgery, while DMM had already generated changes in the articular cartilage, such as partial loss of proteoglycan and surface fibrillation, it had no detectable effect on subchondral bone structure in these mice. All subchondral bone responses in our models require either a substantial period of time after OA initiation or a CKO mouse model that is predisposed to OA development. Moreover, our previous findings revealed that the cartilage surface modulus at future sites of OA is substantially reduced at 1 week after DMM surgery, owing to increased catabolic activities (35) . This time point is much earlier than any detectable emergence of cartilage morphologic changes, let alone subchondral bone alterations. Hence, our data strongly support the idea that subchondral bone sclerosis is secondary to cartilage degeneration.
We were also interested in exploring whether changes in the subchondral bone could exaggerate overlying cartilage degeneration. Sost-KO mice have substantially more trabecular and cortical bone than WT mice (36) . In 1-year-old Sost-KO mice, the STB robustly expands, resulting in a solid bone between articular cartilage and the growth plate (data not shown). Consistent with the results of a previous study (37), we did not detect any cartilage degeneration in Sost-KO mice from ages 3 months up to 14 months (data not shown). Four weeks of sclerostin antibody injections in WT mice also did not alter the articular cartilage, whereas it drastically increased BV/ TV in the STB and thickened the SBP (data not shown).
In contrast to previous findings showing that OA was accelerated in Sost-KO mice after DMM surgery (26), we found that DMMH surgery resulted in symptoms of OA that were similarly severe between WT and Sost-KO mice. Furthermore, a strategy of intermittent injections of parathyroid hormone (PTH) 1-34 peptide, a potent anabolic agent for stimulating bone formation and bone turnover, has been shown to either attenuate OA progression (38) or have no effect in surgery-induced OA models (39) . In our experiments, PTH injections quickly enlarged the SBP within 2-3 weeks but did not accelerate OA progression after DMM (data not shown). More importantly, no clinical study has shown a positive correlation between PTH treatment and incidence of OA in patients with osteoporosis. From a mechanical point of view, thickening of the SBP from the bone marrow side, as we have demonstrated to be the major site of new bone formation during OA, is unlikely to affect the load distribution at the surface of overlying cartilage. We believe that SBP thickening alone is not sufficient to affect cartilage degeneration, and therefore it cannot be an initiator of cartilage and joint damage in OA development. Whether bone alterations in the STB, predicated by enhanced bone turnover, contribute to the progression of OA is still not clear from our studies.
Our studies have several limitations. First, our sham surgery was performed in the contralateral joint rather than in a separate group of mice. Though we did not detect any obvious OA changes in the sham-operated joints, animals may still have altered loading patterns and gaits. Second, DMMH was performed on mice with immature skeletons. We chose this age (8 weeks old) because the SBP in Sost-KO mice continuously thickens throughout their life, thereby making it difficult to accurately measure its thickness in older mice. Third, it is possible that the BFR at the bone marrow side of the SBP of Sost-KO mice has already reached its maximum, and so cannot be further enhanced by the increased loading after cartilage depletion. However, PTH injections have been shown to increase the high basal levels of periosteal and endosteal BFR in the femoral midshaft of Sost-KO mice (40) , suggesting that the BFR in the SBP of Sost-KO mice can be further elevated. Finally, all of our data were derived from mouse models. While mouse models have many advantages in cartilage research, particularly in discovering novel cellular and molecular mechanisms, studies of OA in larger animals are required before we can translate our findings into workable designs for future clinical applications.
In summary, the results of our study establish mechanical loading-induced attenuation of sclerostin expression and elevation of bone formation along the SBP as the major mechanisms responsible for subchondral bone sclerosis associated with late-stage OA. Thus, correcting abnormal loading of the knee joint might be an effective approach for attenuating subchondral bone damage in patients with OA.
